首页> 外国专利> Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors

Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors

机译:可鳞可鳞可鳞状甲状腺蛋白拮抗剂,具有改善的血脑屏障渗透和保留血脑肿瘤

摘要

Chemical compounds/compositions, methods of synthesis, and methods of use. The compounds/compositions are directed toward thyrointegrin antagonists conjugated to a polymer. The compounds/compositions further comprise an additional substituent also conjugated to the polymer. The compounds/compositions demonstrate increased uptake across the blood brain barrier along with increased retention therein and retention within tumor. The compounds/compositions may also include improved synthesis scalability, improved purity, improved aqueous solubility, and a solid product or intermediate. The compounds/compositions may demonstrate improved antiangiogenic effect and improved efficacy against conditions, particularly cancers, requiring blood brain barrier permeability, for example, glioblastoma (GBM).
机译:化学化合物/组合物,合成方法和使用方法。化合物/组合物朝向与聚合物缀合的甲状腺蛋白拮抗剂。化合物/组合物还包含另外的取代基,其与聚合物缀合。化合物/组合物在血脑屏障中表现出增加的摄取以及其中的保留增加并在肿瘤内保持。化合物/组合物还可包括改善的合成可扩展性,改善纯度,改善的水溶性和固体产物或中间体。化合物/组合物可以证明改善的抗血管生成效果和改善对条件,特别是癌症的疗效,例如血脑屏障渗透性,例如胶质母细胞瘤(GBM)。

著录项

  • 公开/公告号US10961204B1

    专利类型

  • 公开/公告日2021-03-30

    原文格式PDF

  • 申请/专利权人 NANOPHARMACEUTICALS LLC;

    申请/专利号US202016862076

  • 发明设计人 SHAKER A. MOUSA;BRUCE A. HAY;

    申请日2020-04-29

  • 分类号C07D249/04;A61P35;

  • 国家 US

  • 入库时间 2022-08-24 17:58:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号